Integra LifeSciences | IART - Gross Profit On Sales

Integra Lifesciences reported $247.95M in Gross Profit on Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Gross Profit On Sales Change
Abbott ABT:US USD 5.5B 283M
Atricure ATRC:US USD 65.11M 3.4M
Baxter International BAX:US USD 1.47B 322M
Becton, Dickinson and BDX:US USD 2.13B 56M
Boston Scientific BSX:US USD 2.22B 18M
Conmed CNMD:US USD 133.96M 19.75M
Cooper Companies COO:US USD 558.5M 14.3M
Dexcom DXCM:US USD 555.2M 61M
Edwards Lifesciences EW:US USD 1.09B 23.6M
Globus Medical GMED:US USD 203.91M 15.26M
Hologic HOLX:US USD 617.9M 95M
Insulet PODD:US USD 217.3M 29M
Integra Lifesciences IART:US USD 247.95M 7M
Intuitive Surgical ISRG:US USD 1.11B 58.8M
Johnson & Johnson JNJ:US USD 15.94B 56M
Medtronic MDT:US USD 5.06B 39M
Merit Medical Systems MMSI:US USD 134.55M 5.98M
Nuvasive NUVA:US USD 214.67M 261K
Orthofix International OFIX:US USD 89.18M 5.75M
Smith & Nephew PLC SN/:LN 1.83B 49M
Stryker SYK:US USD 3.26B 461M
Tandem Diabetes Care TNDM:US USD 115.52M 11.1M
Teleflex TFX:US USD 422.07M 48.11M
Zimmer Biomet Holdings Inc ZBH:US USD 1.3B 123.2M